1Specialist, Department of Psychiatry, Dr Baba Saheb Ambedkar Hospital and Medical College, Rohini-06, Delhi-85, India
2Assistant Professor, Department of Psychiatry, Dr Baba Saheb Ambedkar Hospital and Medical College, Rohini-06, Delhi-85, India
*Correspondence: Dr. Namita Deka, Department of Psychiatry, Dr Baba Saheb Ambedkar Hospital and Medical College, Rohini-06, Delhi-85. India. deka_namita@redifmail.com
Online published on 30 June, 2017.
A young male presented with second episode of depressive symptoms of one month duration; treatment started with fluoxetine and on third week of starting of treatment, he developed sudden onset blurring of vision due to mydriasis which dramatically improved after discontinuation of fluoxetine. There are evidences that selective serotonin reuptake inhibitors (SSRIs) can cause mydriasis through various mechanisms. Ocular side effects are rarely reported with SSRIs and we present such a case highlighting the same.
Depression, Serotonin Uptake Inhibitors, Mydriasis
